A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HCD / higher-energy C-trap dissociation

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HCD  (>> Co-occurring Abbreviation)
Long Form:   higher-energy C-trap dissociation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Analysis of oxidised and glycated aminophospholipids: Complete structural characterisation by C30 liquid chromatography-high resolution tandem mass spectrometry. APL, PE, PS, ROS, RP
2019 Development and Evaluation of a Reverse-Entry Ion Source Orbitrap Mass Spectrometer. REIS
2019 Optimized Fragmentation Improves the Identification of Peptides Cross-Linked by MS-Cleavable Reagents. MS-cleavable, MSn
2017 A Strategy Combining Higher Energy C-Trap Dissociation with Neutral Loss- and Product Ion-Based MSn Acquisition for Global Profiling and Structure Annotation of Fatty Acids Conjugates. DACBs, FACs, VB
2017 An enhanced targeted identification strategy for the selective identification of flavonoid O-glycosides from Carthamus tinctorius by integrating offline two-dimensional liquid chromatography/linear ion-trap-Orbitrap mass spectrometry, high-resolution diagnostic product ions/neutral loss filtering and liquid chromatography-solid phase extraction-nuclear magnetic resonance. CID, FOGs
2015 A green protocol for efficient discovery of novel natural compounds: characterization of new ginsenosides from the stems and leaves of Panax ginseng as a case study. SLP
2015 Carbamidomethylation Side Reactions May Lead to Glycan Misassignments in Glycopeptide Analysis. ETD
2015 Characteristic tandem mass spectral features under various collision chemistries for site-specific identification of protein S-glutathionylation. CID, ETD, MS
2015 Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry. CEX, LC/MS, mAb, MS
10  2015 High-resolution enabled 12-plex DiLeu isobaric tags for quantitative proteomics. iTRAQ, TMT
11  2014 Computational framework for identification of intact glycopeptides in complex samples. CID, ETD
12  2014 In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation. CID, HCC, HILIC
13  2014 Multiplexed parallel reaction monitoring targeting histone modifications on the QExactive mass spectrometer. PRM, SRM
14  2013 Discrimination of cyclic and linear oligosaccharides by tandem mass spectrometry using collision-induced dissociation (CID), pulsed-Q-dissociation (PQD) and the higher-energy C-trap dissociation modes. CID, PQD
15  2013 Glycoproteomic analysis of the secretome of human endothelial cells. ETD
16  2013 Method for characterization of PEGylated bioproducts in biological matrixes. LC/MS, LOQ, PPA
17  2012 Detection and characterization of low abundance glycopeptides via higher-energy C-trap dissociation and orbitrap mass analysis. HexNAc
18  2012 Fragmentation methods on the balance: unambiguous top-down mass spectrometric characterization of oxaliplatin-ubiquitin binding sites. CID, ESI-MS, ETD, ICR, MS/MS, Ub
19  2011 Combining high-energy C-trap dissociation and electron transfer dissociation for protein O-GlcNAc modification site assignment. ETD, O-GlcNAc
20  2011 Improving confidence in detection and characterization of protein N-glycosylation sites and microheterogeneity. CID, MS
21  2011 Sulfate migration in oligosaccharides induced by negative ion mode ion trap collision-induced dissociation. CID, M - H
22  2010 Analysis of root plasma membrane aquaporins from Brassica oleracea: post-translational modifications, de novo sequencing and detection of isoforms by high resolution mass spectrometry. CID, PTMs
23  2010 Characterizing protein glycosylation sites through higher-energy C-trap dissociation. ---
24  2010 Combining low- and high-energy tandem mass spectra for optimized peptide quantification with isobaric tags. CID, PQD, TMTs
25  2010 Identification of NTBC metabolites in urine from patients with hereditary tyrosinemia type 1 using two different mass spectrometric platforms: triple stage quadrupole and LTQ-Orbitrap. CID, FTMS, HT-1, MS, SRM
26  2010 Isobaric tagging-based selection and quantitation of cerebrospinal fluid tryptic peptides with reporter calibration curves. CID, CSF, MS, MS/MS, OGE, RPLC, TMTs
27  2009 High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all. CID, iTRAQ, PQD
28  2007 Higher-energy C-trap dissociation for peptide modification analysis. MS/MS